DuoGenic StemCells corporation
7607
Rank in Stocks
#27719
Duogenic Stemcells Corporation is primarily engaged in the biotechnology and... Duogenic Stemcells Corporation is primarily engaged in the biotechnology and healthcare industries, offering a variety of services. Their core offerings include cell therapy and the development of closed-culture cell systems. The company was established on March 22, 2018, and its main corporate office is situated in Taichung, Taiwan.
Share Price
$0.37800729
Last synced: 2026-11-10
Market Cap
$13.86M
Change (1 day)
5.08%
Change (1 year)
-35.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DuoGenic StemCells corporation (7607)
Category
Healthcare
EPS for DuoGenic StemCells corporation (7607)
EPS as of June 2026 TTM: $-0.03
According to DuoGenic StemCells corporation's latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.03, an increase over its 2024 EPS of $-0.06.
EPS history for DuoGenic StemCells corporation from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | 5.00% |
| 2025 | $-0.03 | -55.23% |
| 2024 | $-0.06 | 25.15% |
| 2023 | $-0.05 | 27.01% |
| 2022 | $-0.04 | 24.19% |
| 2021 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | -26,925.40% |
IE
|
|
| $0.21 | -761.90% |
CN
|
|
| $19.69 | -62,604.13% |
CH
|
|
| $4.34 | -13,871.43% |
CH
|
|
| $0.13 | -500.00% |
CN
|
Questions about DuoGenic StemCells corporation's earnings per share (EPS)
What is DuoGenic StemCells corporation's earnings per share (EPS)?
DuoGenic StemCells corporation's earnings per share (EPS) over the last twelve months is $-0.03, as of Jun 2026.
What was DuoGenic StemCells corporation's earnings per share (EPS) in 2025?
In 2025, DuoGenic StemCells corporation's earnings per share (EPS) was $-0.03, compared with $-0.06 in 2024.
How has DuoGenic StemCells corporation's earnings per share (EPS) changed since 2021?
From 2021 to 2025, DuoGenic StemCells corporation's earnings per share (EPS) was highest in 2025 ($-0.03) and lowest in 2024 ($-0.06).
How does DuoGenic StemCells corporation's earnings per share (EPS) compare with similar companies?
DuoGenic StemCells corporation's earnings per share (EPS) ($-0.03) is lower than that of all 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $19.69.